(16) found that in patients with symptomatic COVID-19 and aTB the level of IFN-γ produced in response to SARS-CoV-2 specific CD4S antigen was lower compared to patients with only COVID-19 or COVID-19 and LTBI coinfection. The gene discussed is IFNG; the disease is COVID-19.